• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Is DENTSPLY SIRONA (XRAY) A Bargain After Cutting 2026 Sales Guidance?

    Simply Wall St·11/10/2026 14:23:58
    Listen to the news

    DENTSPLY SIRONA (XRAY) reset expectations on 5 November, cutting its 2026 sales outlook to about US$3.5b and pairing that update with fresh third quarter results and lower impairment charges.

    For DENTSPLY SIRONA, the reset in 2026 guidance lands after a mixed stretch in the market, with the share price up 8.0% over 30 days even as the 90 day share price return declined 17.8% and the 5 year total shareholder return fell 80.7%. This suggests short term momentum is picking up against a much weaker long term record as investors reassess both execution risk and recovery potential.

    Scan how other dental and healthcare equipment stocks are priced for similar guidance resets by reviewing our hand picked 33 high quality undervalued stocks alongside DENTSPLY SIRONA.

    DENTSPLY SIRONA now trades near multi year lows after cutting its 2026 sales outlook. The real tension is whether investors press the buy button today or wait for an even cheaper entry as the valuation work begins.

    Most Popular Narrative: 23% Undervalued

    DENTSPLY SIRONA’s analyst consensus Narrative on Simply Wall St pegs fair value at $12.40 per share, compared with the last close at $9.54. That gap frames a thesis that focuses on execution in digital tools, restructuring, and Wellspect to help close it.

    Restructuring actions are freeing about US$120 million that is being redirected into R&D, clinical education, and sales capability, along with higher R&D investment of roughly US$25 million. This can support a richer product pipeline and improved mix that may benefit net margins and long term earnings power.

    What is behind that potential earnings lift is summarised in 10 investors see DENTSPLY SIRONA as 23% undervalued.

    Result: Fair Value of $12.40 (UNDERVALUED)

    Still, the narrative around DENTSPLY SIRONA can break quickly if revenue pressure persists or if higher margin categories like implants and SureSmile remain weak.

    Find out about the key risks to this DENTSPLY SIRONA narrative.

    Next Steps

    Sentiment in the DENTSPLY SIRONA story is split, so act quickly, pressure test the assumptions, and weigh the upside for yourself using the 3 key rewards.

    Looking for more investment ideas beyond DENTSPLY SIRONA?

    If DENTSPLY SIRONA has you rethinking your watchlist, now is the moment to widen your search and uncover other opportunities before they move without you.